BridgeMD
New treatment option for Mild Cognitive Impairment (MCI)
Official title Validation of a Digital Intervention to Rehabilitate Cognitive Resources
ClinicalTrials.gov ID: NCT07064226
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if the use of a digital cognitive rehabilitation system named RICORDO, that is flexible and capable of adapting the rehabilitation pathway according to the needs and capacity of the patients will prove effective for subjects with Subjective Memory Complaint or with Mild Cognitive Impairment or with Mild Dementia. The main questions it aims to answer are: Will the RICORDO rehabilitation treatment, lead to an improvement in the global cognitive level?
- Time commitment: about 5 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Montreal Cognitive Assessment (MoCA) score \> 17.79;
- Clinical Dementia Rating (CDR) Scale score ≤ 1;
- Education level \> 3 years;
- Age ≥ 65 years;
- Informed consent to participate, confirmed by signing the consent form;
You likely can't join if
- Presence of dysmetria or marked auditory/visual or communication disorders preventing the participation to the trial;
- Presence of ongoing rehabilitation program at the time of enrollment or in the 3 months prior to enrollment;
See the full eligibility criteria
- Montreal Cognitive Assessment (MoCA) score \> 17.79;
- Clinical Dementia Rating (CDR) Scale score ≤ 1;
- Education level \> 3 years;
- Age ≥ 65 years;
- Informed consent to participate, confirmed by signing the consent form;
- Availability of a caregiver/study partner able to support the participant;
- Stable pharmacological treatment (past 3 months) with acetylcholinesterase inhibitors, if applicable.
- Presence of dysmetria or marked auditory/visual or communication disorders preventing the participation to the trial;
- Presence of ongoing rehabilitation program at the time of enrollment or in the 3 months prior to enrollment;
The study team makes the final eligibility decision.
Where it's taking place
- Milan, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 5 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Milan, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.